| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/03/2000 | EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 05/03/2000 | EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
| 05/03/2000 | EP0996723A1 Human phosphatidylinositol transfer protein gamma |
| 05/03/2000 | EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 05/03/2000 | EP0996715A1 Heterologous expression of proteins by "rescued" vector comprising an intron |
| 05/03/2000 | EP0996639A2 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines |
| 05/03/2000 | EP0996638A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
| 05/03/2000 | EP0996636A1 The ha-1 antigen |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996634A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 05/03/2000 | EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
| 05/03/2000 | EP0996628A2 Mammalian neuro-growth factor like protein |
| 05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
| 05/03/2000 | EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
| 05/03/2000 | EP0873521A4 Method for potentiating tissue plasminogen activators |
| 05/03/2000 | EP0668908B1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 05/03/2000 | EP0560947B1 Trivalent monospecific antigen binding proteins |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | CN1252076A Production of antihuman antigen receptors and use thereof |
| 05/03/2000 | CN1251861A Human T cell activating protein gene and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251860A Human gene sequence and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251840A Constitutive fusion protein of ridamycin as anticancer antibiotic and single-chain antibody |
| 05/02/2000 | US6057436 Canine coronavirus S gene and uses therefor |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057433 Nucleotide sequences; used for screening compounds which bind to the receptor or which suppress ligand binding to the receptor |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057423 Screening a recombinantly-produced or chemically-synthesized molecular library to identify compounds which suppress binding between human mucosal lymphocyte-1 antigen comprising an integrin alpha e chain and an epithelial cell in vitro |
| 05/02/2000 | US6057421 Variable heavy and light chain regions of murine monoclonal antibody 1F7 |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057121 Method of catalyzing stereochemical reactions |
| 05/02/2000 | US6057116 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 05/02/2000 | US6057115 Process for producing GM2 specific antibodies |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057111 Detection of genes for maintenance of specific cell phenotypes; isolating cell type with phenotype of interest, deactivating genes, isolating cells which maintain phenotype, use subtractive analysis to screen for maintainence gene |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6057098 Preparing genetically engineered phage envelope protein; providing phage packages coding varying number of envelope protein, contacting the library with a receptor, separating phage packages |
| 05/02/2000 | US6056963 Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056958 Administering a therapeutically effective amount of a monoclonal antibody having a laboratory designation selected from the group consisting of; lm609; 10c4.1.3; 9g2.1.3; and 9d1.9.1 |
| 05/02/2000 | US6056957 Humanized monoclonal antibodies against human interleukin-5 |
| 05/02/2000 | US6056956 Non-depleting anti-CD4 monoclonal antibodies and tolerance induction |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 04/30/2000 | CA2253152A1 Use of anti-porin compounds for reducing injury to mammalian cells |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023806A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | WO2000023625A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 04/27/2000 | WO2000023595A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | WO2000023593A2 Molecular pathogenicide mediated plant disease resistance |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023586A1 HUMAN PROTEIN Grf40 AND cDNA THEREOF |
| 04/27/2000 | WO2000023579A1 Functionally assembled antigen-specific intact recombinant antibody and a method for production thereof |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023573A2 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023477A2 Immunoglobulin variants |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023110A1 Methods and agents for inducing apoptosis and methods for their identification |
| 04/27/2000 | WO2000023109A1 Glypicans for the detection and treatment of human carcinoma |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023088A2 Methods of administering adenoviral vectors |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000023082A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | WO2000012559B1 Monoclonal antibodies against s100 |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004383A3 Hiv group o positive control |
| 04/27/2000 | WO2000001732A3 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/27/2000 | WO1999067282A3 Olfactory receptors and their uses |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999064073A9 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19845286A1 New carrier material coated with specific antibodies, used to remove tumor necrosis factor and other disease-associated compounds from blood, for treating arthritis or pyelonephritis |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2633345A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | CA2354862A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2347849A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347083A1 Methods of administering adenoviral vectors |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |